KR20140028069A - 이미다졸 유도체의 제조 방법 - Google Patents

이미다졸 유도체의 제조 방법 Download PDF

Info

Publication number
KR20140028069A
KR20140028069A KR1020137032819A KR20137032819A KR20140028069A KR 20140028069 A KR20140028069 A KR 20140028069A KR 1020137032819 A KR1020137032819 A KR 1020137032819A KR 20137032819 A KR20137032819 A KR 20137032819A KR 20140028069 A KR20140028069 A KR 20140028069A
Authority
KR
South Korea
Prior art keywords
compound
added
mixture
stirred
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137032819A
Other languages
English (en)
Korean (ko)
Inventor
요이치 가와바타
야스히로 사와이
가즈아키 간노
나오타카 사와다
Original Assignee
다케다 야쿠힌 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46458578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140028069(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 다케다 야쿠힌 고교 가부시키가이샤 filed Critical 다케다 야쿠힌 고교 가부시키가이샤
Publication of KR20140028069A publication Critical patent/KR20140028069A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020137032819A 2011-06-15 2012-06-14 이미다졸 유도체의 제조 방법 Withdrawn KR20140028069A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2011-133712 2011-06-15
JP2011133712 2011-06-15
PCT/JP2012/065795 WO2012173280A1 (en) 2011-06-15 2012-06-14 Production method of imidazole derivatives

Publications (1)

Publication Number Publication Date
KR20140028069A true KR20140028069A (ko) 2014-03-07

Family

ID=46458578

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137032819A Withdrawn KR20140028069A (ko) 2011-06-15 2012-06-14 이미다졸 유도체의 제조 방법

Country Status (27)

Country Link
US (2) US9278938B2 (enExample)
EP (1) EP2721010B1 (enExample)
JP (1) JP6082353B2 (enExample)
KR (1) KR20140028069A (enExample)
CN (1) CN103608334B (enExample)
AR (1) AR086926A1 (enExample)
AU (1) AU2012270496A1 (enExample)
BR (1) BR112013030888A2 (enExample)
CA (1) CA2838971C (enExample)
CL (1) CL2013003492A1 (enExample)
CO (1) CO6852075A2 (enExample)
CR (1) CR20130655A (enExample)
DO (1) DOP2013000287A (enExample)
EA (1) EA201490019A1 (enExample)
EC (1) ECSP14013128A (enExample)
ES (1) ES2554454T3 (enExample)
IL (1) IL229566A0 (enExample)
MA (1) MA35809B1 (enExample)
MX (1) MX2013014009A (enExample)
PE (1) PE20141326A1 (enExample)
PH (1) PH12013502567A1 (enExample)
SG (1) SG195036A1 (enExample)
TN (1) TN2013000481A1 (enExample)
TW (1) TW201307295A (enExample)
UY (1) UY34130A (enExample)
WO (1) WO2012173280A1 (enExample)
ZA (1) ZA201308884B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210012112A (ko) * 2019-07-24 2021-02-03 (주)에니켐텍 신규한 메데토미딘 제조방법

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016054129A1 (en) * 2014-09-30 2016-04-07 Stc.Unm Graphene-based inorganic-organic hybrid materials and separation of racemic mixtures
US20200033307A1 (en) * 2018-07-25 2020-01-30 Honeywell International Inc. Method of determining an amount of water in a sample using a derivative of imidazole and a hydrogen halide donor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832880A (ja) * 1981-08-24 1983-02-25 Isukura Sangyo Kk ハリントニンの部分合成方法
US6713632B1 (en) 1999-06-22 2004-03-30 Takeda Chemical Industries, Ltd. Process for the preparation of imidazole derivatives
PE20010781A1 (es) 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
DE10031604A1 (de) 2000-06-29 2002-01-17 Consortium Elektrochem Ind Verfahren zur Herstellung von beta-Hydroxy- und beta-Aminocarbonylverbindungen
TWI306099B (en) 2000-11-17 2009-02-11 Takeda Chemical Industries Ltd Novel imidazole derivatives, production method thereof and use thereof
CN1289434C (zh) 2002-01-04 2006-12-13 皇家飞利浦电子股份有限公司 烧结体和电灯
US7662974B2 (en) * 2002-01-10 2010-02-16 Takeda Pharmaceutical Company Limited Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
EP1394140A1 (de) * 2002-08-14 2004-03-03 Consortium für elektrochemische Industrie GmbH Enantioselektives Reformatsky-Verfahren zur Herstellung von optisch aktiven Alkoholen, Aminen und deren Derivaten
EP2164409B1 (en) 2007-06-29 2018-08-08 Atheromed, Inc. Atherectomy system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210012112A (ko) * 2019-07-24 2021-02-03 (주)에니켐텍 신규한 메데토미딘 제조방법

Also Published As

Publication number Publication date
ECSP14013128A (es) 2014-02-28
ZA201308884B (en) 2015-02-25
EA201490019A1 (ru) 2014-04-30
CN103608334A (zh) 2014-02-26
CA2838971C (en) 2019-07-30
AU2012270496A1 (en) 2013-12-19
JP6082353B2 (ja) 2017-02-15
CN103608334B (zh) 2015-12-23
US20140100373A1 (en) 2014-04-10
US10005780B2 (en) 2018-06-26
SG195036A1 (en) 2013-12-30
TW201307295A (zh) 2013-02-16
PH12013502567A1 (en) 2014-01-27
CO6852075A2 (es) 2014-01-30
CL2013003492A1 (es) 2014-07-18
DOP2013000287A (es) 2014-02-16
MX2013014009A (es) 2014-03-12
AR086926A1 (es) 2014-01-29
EP2721010B1 (en) 2015-09-09
TN2013000481A1 (en) 2015-03-30
CR20130655A (es) 2014-03-03
ES2554454T3 (es) 2015-12-21
CA2838971A1 (en) 2012-12-20
UY34130A (es) 2013-01-31
EP2721010A1 (en) 2014-04-23
PE20141326A1 (es) 2014-10-16
JP2014520066A (ja) 2014-08-21
BR112013030888A2 (pt) 2017-03-21
MA35809B1 (fr) 2014-12-01
US9278938B2 (en) 2016-03-08
WO2012173280A1 (en) 2012-12-20
US20160244454A1 (en) 2016-08-25
IL229566A0 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
US7301027B2 (en) Process for the preparation of Imiquimod and intermediates thereof
CN116987112B (zh) 制备氨基嘧啶衍生物的改善方法
HU227492B1 (en) Intermediates for the preparation of agents having antifungal activity, processes for the preparation thereof
IL197527A (en) History - 4-Oxoquoquinoline and Process and Intermediate Compounds for Preparation of Integration Inhibitors
TW202233569A (zh) 製備3—氟—5—(((1S,2aR)—1,3,3,4,4—五氟—2a—羥基—2,2a,3,4—四氫—1H—環戊[cd]茚—7—基)氧基)苯甲腈之方法
US20200207750A1 (en) Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same
JP2022520698A (ja) 3-メチル-1,2,4-チアジアゾール-5-カルボヒドラジドまたはそのメチル-d3重水素化形態の合成
US10005780B2 (en) Production method of imidazole derivatives
JP4528123B2 (ja) ナプロキセンのニトロオキシ誘導体の製造法
CN110028451B (zh) 一种全取代吡唑衍生物制备方法
US20070185332A1 (en) Process for the synthesis of imidazoles
JP2004161726A (ja) 縮合イミダゾール化合物の製造方法、ならびに安定な形態のリフォルマツキー試薬およびその製造方法
EP3915984A1 (en) SYNTHESIS OF 3-BROMO-5-(2-ETHYLIMIDAZO[1,2-alpha]PYRIDINE-3-CARBONYL)-2-HYDROXYBENZONITRILE
CN113816955B (zh) 一种ret激酶抑制剂中间体及其制备方法
JP4061333B2 (ja) 2−(ピラゾール−1−イル)ピリジン誘導体
US7880017B2 (en) Process for the synthesis of imidazoles
CN120647647A (zh) 一类β-咔啉类化合物的合成方法
US20040015018A1 (en) Water as promoter in the nucleophilic substitution of chloride
JP2022035954A (ja) N-Boc-ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法
EP1471058A1 (en) Process for producing 1,2,3-triazole compound
HK40056618B (en) Synthesis of 3-bromo-5-(2-ethylimidazo[1,2-alpha]pyridine-3-carbonyl)-2-hydroxybenzonitrile
HK40056618A (en) Synthesis of 3-bromo-5-(2-ethylimidazo[1,2-alpha]pyridine-3-carbonyl)-2-hydroxybenzonitrile
CN1290247A (zh) 制备抗叶酸剂的方法和中间体
JP2004244362A (ja) 1,2−ジ置換−1,4−ジヒドロ−オキソキノリン誘導体の製造方法
JPS58216166A (ja) N−置換イミダゾ−ル類の製造法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000